View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Our new building on the hospital campus, Forest B, is open. Families and visitors can park in the new Forest B garage next to Emergency.

Clinical Trial Search block Test

Efficacy, safety, and pharmacokinetics of vericiguat in pediatric participants with heart failure due to left ventricular systolic dysfunction

VALOR

Phase: II/III

What is the goal of the study?

Phase 2/3 adaptive randomized, placebo-controlled, parallel-group, multisite, double-blind study of vericiguat in pediatric participants with HF due to LV systolic dysfunction consistent with dilated cardiomyopathy and NT-proBNP level between 500 and 6000 pg/mL within 30 days before randomization.

Who can participate in the study?

Everyone

Study Team:

PI (Study Doctor): Yuk Law
Study Team Member: Annabeth Evans, Annabeth.Evans@seattlechildrens.org